1. Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria. Issue 4 (8th March 2017) Authors: Smolen, Josef S.; Aletaha, Daniel; Gruben, David; Zwillich, Samuel H.; Krishnaswami, Sriram; Mebus, Charles Journal: Arthritis & rheumatology Issue: Volume 69:Issue 4(2017) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data. Issue 5 (3rd September 2019) Authors: Takeuchi, Tsutomu; Yamanaka, Hisashi; Yamaoka, Kunihiro; Arai, Shoko; Toyoizumi, Shigeyuki; DeMasi, Ryan; Fukuma, Yuri; Hirose, Tomohiro; Sugiyama, Naonobu; Zwillich, Samuel H.; Tanaka, Yoshiya Journal: Modern rheumatology Issue: Volume 29:Issue 5(2019) Page Start: 756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies. (25th July 2016) Authors: Fleischmann, Roy; Kremer, Joel; Tanaka, Yoshiya; Gruben, David; Kanik, Keith; Koncz, Tamas; Krishnaswami, Sriram; Wallenstein, Gene; Wilkinson, Bethanie; Zwillich, Samuel H.; Keystone, Edward Journal: International journal of rheumatic diseases Issue: Volume 19:Number 12(2016) Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient's perspective. (July 2014) Authors: Rendas-Baum, Regina; Bayliss, Martha; Kosinski, Mark; Raju, Aditya; Zwillich, Samuel H.; Wallenstein, Gene V.; Koncz, Tamas Journal: Current medical research and opinion Issue: Volume 30:Number 7(2014:Jul.) Page Start: 1391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers. Issue 1 (11th November 2019) Authors: Miyoshi, So; Krishnaswami, Sriram; Toyoizumi, Shigeyuki; Nakamura, Hiroyuki; Zwillich, Samuel H. Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 1(2020) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to Dr Minota's Letter to the Editor of Modern Rheumatology Regarding a Study of Tofacitinib in Japanese Patients with Rheumatoid Arthritis. Issue 2 (3rd March 2016) Authors: Tanaka, Yoshiya; Zwillich, Samuel H. Journal: Modern rheumatology Issue: Volume 26:Issue 2(2016) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study. Issue 3 (25th February 2013) Authors: van der Heijde, Désirée; Tanaka, Yoshiya; Fleischmann, Roy; Keystone, Edward; Kremer, Joel; Zerbini, Cristiano; Cardiel, Mario H.; Cohen, Stanley; Nash, Peter; Song, Yeong‐Wook; Tegzová, Dana; Wyman, Bradley T.; Gruben, David; Benda, Birgitta; Wallenstein, Gene; Krishnaswami, Sriram; Zwillich, Sa... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 3(2013:Mar.) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study12. Issue 3 (25th February 2013) Authors: van der Heijde, Désirée; Tanaka, Yoshiya; Fleischmann, Roy; Keystone, Edward; Kremer, Joel; Zerbini, Cristiano; Cardiel, Mario H.; Cohen, Stanley; Nash, Peter; Song, Yeong‐Wook; Tegzová, Dana; Wyman, Bradley T.; Gruben, David; Benda, Birgitta; Wallenstein, Gene; Krishnaswami, Sriram; Zwillich, Sa... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 3(2013:Mar.) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study12. Issue 3 (25th February 2013) Authors: van der Heijde, Désirée; Tanaka, Yoshiya; Fleischmann, Roy; Keystone, Edward; Kremer, Joel; Zerbini, Cristiano; Cardiel, Mario H.; Cohen, Stanley; Nash, Peter; Song, Yeong‐Wook; Tegzová, Dana; Wyman, Bradley T.; Gruben, David; Benda, Birgitta; Wallenstein, Gene; Krishnaswami, Sriram; Zwillich, Sa... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 3(2013:Mar.) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tofacitinib in Combination With Conventional Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient‐Reported Outcomes From a Phase III Randomized Controlled Trial. Issue 4 (April 2017) Authors: Strand, Vibeke; Kremer, Joel M.; Gruben, David; Krishnaswami, Sriram; Zwillich, Samuel H.; Wallenstein, Gene V. Journal: Arthritis care & research Issue: Volume 69:Issue 4(2017:Apr.) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗